|
N
|
48
|
31
|
51
|
–
|
|
Age (years), mean (SD)
|
53.15 (11.61)
|
57.13 (11.22)
|
54.78 (12.39)
|
0.35
|
|
Male, n (%)
|
33 (68.75%)
|
27 (87.10%)
|
41 (80.39%)
|
0.16
|
|
Hypertension, n (%)
|
22 (45.83%)
|
25 (80.65%)
|
34 (66.67%)
|
0.006
|
|
Diabetes mellitus, n (%)
|
1 (2.08%)
|
3 (9.68%)
|
4 (7.84%)
|
0.37
|
|
COPD, n (%)
|
2 (4.17%)
|
1 (3.23%)
|
3 (5.88%)
|
1.00
|
|
Stroke, n (%)
|
3 (6.25%)
|
2 (6.45%)
|
3 (5.88%)
|
1.00
|
|
Coronary artery disease, n (%)
|
1 (2.08%)
|
4 (12.90%)
|
2 (3.92%)
|
0.12
|
|
SBP (mmHg), mean (SD)
|
131.90 (22.70)
|
125.39 (27.54)
|
140.27 (32.43)
|
0.06
|
|
DBP (mmHg), mean (SD)
|
71.02 (16.53)
|
66.71 (21.57)
|
78.49 (19.15)
|
0.018
|
|
eGFR [ml/(min.1.73m2)], mean (SD)
|
100.57 (30.65)
|
71.53 (22.21)
|
94.84 (51.22)
|
0.007
|
|
Preoperative hemoglobin (g/l), mean (SD)
|
125.87 (18.39)
|
120.77 (22.74)
|
124.53 (22.44)
|
0.61
|
|
Emergency operation, n (%)
|
21 (43.75%)
|
25 (80.65%)
|
42 (82.35%)
|
< 0.001
|
|
CPB time (min), median (IQR)
|
176 (120–221)
|
173 (132–212)
|
210 (185–244)
|
0.001
|
|
Aortic cross clamp time (min), median (IQR)
|
96 (76–118)
|
96 (74–107)
|
120 (95–127)
|
0.004
|
|
Circulatory arrest time (min), median (IQR)
|
12 (0–20)
|
15 (0–24)
|
18 (8–24)
|
0.26
|
|
Nasopharyngeal temperature (°C), mean (SD)
|
20.9 (2.1)
|
20.8 (2.1)
|
20.4 (2.5)
|
> 0.05
|
|
Total arch replacement, n (%)
|
20 (41.67%)
|
18 (58.06%)
|
38 (74.51%)
|
0.004
|
|
Semi-arch replacement, n (%)
|
2 (4.17%)
|
1 (3.23%)
|
0 (0.00%)
|
0.35
|
|
Stented elephant trunk, n (%)
|
19 (39.58%)
|
17 (54.84%)
|
36 (70.59%)
|
0.008
|
|
Bentall procedure, n (%)
|
27 (56.25%)
|
14 (45.16%)
|
14 (27.45%)
|
0.014
|
|
Ascending aorta replacement, n (%)
|
21 (43.75%)
|
17 (54.84%)
|
35 (68.63%)
|
0.044
|
|
Intraoperative erythrocytes use (ml), median (IQR)
|
1750 (1050–3375)
|
2200 (1400–2775)
|
2950 (1950–4350)
|
0.007
|
|
Intraoperative fresh frozen plasma use (ml), median (IQR)
|
850 (550–1200)
|
1000 (575–1550)
|
1000 (550–1925)
|
0.55
|
|
Intraoperative platelets use (ml), median (IQR)
|
600 (300–1200)
|
1200 (900–1200)
|
1200 (750–1200)
|
0.006
|
|
Intraoperative cryoprecipitate use (ml), median (IQR)
|
350 (0–500)
|
475 (250–525)
|
500 (250–560)
|
0.11
|
|
Intraoperative blood transfusion(ml), median (IQR)
|
2825 (1988–5538)
|
4400 (2750–5800)
|
4850 (3650–6875)
|
0.007
|
|
ARDS, n (%)
|
8 (16.67%)
|
13 (41.94%)
|
31 (60.78%)
|
< 0.001
|
|
Perioperative myocardial infarction, n (%)
|
0 (0.00%)
|
0 (0.00%)
|
2 (3.92%)
|
0.342
|
|
Redo surgery, n (%)
|
2 (4.17%)
|
3 (9.68%)
|
13 (25.49%)
|
0.007
|
|
Length of ICU (day), median (IQR)
|
4.00 (2.75–5.25)
|
6.00 (3.50–6.50)
|
9.00 (3.00–14.50)
|
0.001
|
|
Length of mechanical ventilation (day), median (IQR)
|
2.00 (1.00–3.00)
|
2.00 (1.00–4.00)
|
5.00 (2.00–7.50)
|
< 0.001
|
|
In-hospital mortality, n (%)
|
2 (4.17%)
|
5 (16.13%)
|
14 (27.45%)
|
0.005
|
